Why the study?
Does initial metabolic tumor volume measured by 18F-FDG PET/CT predict metastasis-free survival in patients with stage II extremity osteosarcoma?
Does initial metabolic tumor volume measured by 18F-FDG PET/CT predict metastasis-free survival in patients with stage II extremity osteosarcoma?
Initial metabolic tumor volume measured by 18F-FDG PET/CT is an independent predictor of metastasis in patients with extremity osteosarcoma.
No takes yet. Share an insight, caveat, or question.
May refine prognosis in stage II osteosarcoma; hypothesis-generating pending prospective validation.
Byun et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: